LASN01
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Lassen Therapeutics 1 PTY LTD
Overview
LASN01 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
LASN01 clinical trials
Explore related
Medical disclaimer. This page summarizes research about LASN01 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.